Headlines
-
AD drug knocked back
Tuesday | Mar 4 2025The Therapeutic Goods Administration (TGA) has confirmed its initial decision from Oct 2024 not to register lecanemab in Australia for use as an amyloid-lowering therapy for the treatment of mild cognitive impairment due to Alzheimer's disease and mild Alzheimer's dementia (early Alzheimer's disease).
-
Systems focus for WOD
Tuesday | Mar 4 2025WORLD Obesity Day (WOD) takes place today, with this year's theme shining a spotlight on the systems that shape our health: 'Changing systems.
-
Yindyamarra: AdPha’s vision for 2030
Tuesday | Mar 4 2025ADVANCED Pharmacy Australia (AdPha) has released its six-year strategic plan, with the patient at the heart of everything they do.
-
AD drug knocked back
Tuesday | Mar 4 2025The Therapeutic Goods Administration (TGA) has confirmed its initial decision from Oct 2024 not to register lecanemab in Australia for use as an amyloid-lowering therapy for the treatment of mild cognitive impairment due to Alzheimer's disease and mild Alzheimer's dementia (early Alzheimer's disease).
-
PSA recognises NSW excellence
Monday | Mar 3 2025THE Pharmaceutical Society of Australia (PSA) has announced the winners of the PSA NSW Excellence Awards, recognising outstanding pharmacists who have demonstrated excellence in their practice and dedication to improving healthcare outcomes for their communities.
-
Arexvy safety data out
Monday | Mar 3 2025AUSVAXSAFETY has published the first Australian safety data on Arexvy respiratory syncytial virus (RSV) vaccination in people aged 60 years and older, reporting low adverse event rates.
-
Prison opioid guidelines
Monday | Mar 3 2025BURNET Institute researchers, in partnership with Western Health, have developed recommendations for the use of opioid agonist treatment in custodial settings, with pharmacists playing a key role in providing continuity of care between prison and after release.
-
Thanks for stepping up
Friday | Feb 28 2025THE Pharmaceutical Society of Australia (PSA) has announced the theme for 2025 Thank Your Pharmacist Day on 13 Mar.
-
Call to raise migraine target
Friday | Feb 28 2025NEW migraine treatment recommendations suggest raising the target reduction of migraine days from the current standard of 50% reduction to 90-100%.
-
AdPha and RACGP team up on transition
Thursday | Feb 27 2025ADVANCED Pharmacy Australia (AdPha) and the Royal Australian College of General Practitioners (RACGP) have released the Transitions of Care resource for doctors, pharmacists and patients.
